Literature DB >> 7494915

Use of the Epworth Sleepiness Scale to demonstrate response to treatment with nasal continuous positive airways pressure in patients with obstructive sleep apnoea.

F M Hardinge1, D J Pitson, J R Stradling.   

Abstract

The Epworth Sleepiness Scale (ESS) was used to measure the degree of daytime sleepiness in two groups of patients with obstructive sleep apnoea (OSA), before and after treatment with nasal continuous positive airways pressure (CPAP). One group (50 patients) were assessed after 2 months CPAP treatment after which the mean ESS fell from 16.4 [standard error of mean (SEM) 0.52] to 7.0 (SEM 0.56). A second group (25 patients) were assessed after 1 yr of treatment: a similar fall in mean ESS was seen from 15.2 (SEM 1.13) before treatment to 6.0 (SEM 0.72). These results imply that the ESS can be used clinically to demonstrate the response of daytime sleepiness in OSA to treatment with CPAP, and that the fall in ESS seen after 2 months is sustained after 1 yr of treatment. It is also possible that this approach could be used to monitor the progress of treatment with CPAP.

Entities:  

Mesh:

Year:  1995        PMID: 7494915     DOI: 10.1016/0954-6111(95)90230-9

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  22 in total

1.  Can mandibular advancement devices be a satisfactory substitute for short term use in patients on nasal continuous positive airway pressure?

Authors:  D M Smith; J R Stradling
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

Review 2.  Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; N J Douglas
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

3.  Prevalence of High Epworth Sleepiness Scale scores in a rural population.

Authors:  P Pahwa; C P Karunanayake; L Hagel; J A Gjevre; D Rennie; J Lawson; J A Dosman
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

4.  Evaluation of an auto-CPAP device for treatment of obstructive sleep apnoea.

Authors:  J H Ficker; G H Wiest; G Lehnert; B Wiest; E G Hahn
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

5.  Obstructive Sleep Apnea and Quality of Life: Comparison of the SAQLI, FOSQ, and SF-36 Questionnaires.

Authors:  Graciela E Silva; James L Goodwin; Kimberly D Vana; Stuart F Quan
Journal:  Southwest J Pulm Crit Care       Date:  2016

6.  The Serbian version of the Epworth Sleepiness Scale.

Authors:  Ivan Kopitovic; Nikola Trajanovic; Sinisa Prodic; Mirjana Jovancevic Drvenica; Miroslav Ilic; Vesna Kuruc; Marija Kojicic
Journal:  Sleep Breath       Date:  2010-11-05       Impact factor: 2.816

7.  Outcome of CPAP treatment on intimate and sexual relationships in men with obstructive sleep apnea.

Authors:  Judith L Reishtein; Greg Maislin; Terri E Weaver
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

8.  Low repeatability of Epworth Sleepiness Scale after short intervals in a sleep clinic population.

Authors:  Fabian A Grewe; Maurice Roeder; Matteo Bradicich; Esther I Schwarz; Ulrike Held; Sira Thiel; Thomas Gaisl; Noriane A Sievi; Malcolm Kohler
Journal:  J Clin Sleep Med       Date:  2020-02-10       Impact factor: 4.062

9.  The complex sleep apnea resolution study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy.

Authors:  Timothy I Morgenthaler; Tomasz J Kuzniar; Lisa F Wolfe; Leslee Willes; William C McLain; Rochelle Goldberg
Journal:  Sleep       Date:  2014-05-01       Impact factor: 5.849

10.  Armodafinil in the treatment of sleep/wake disorders.

Authors:  Jonathan R L Schwartz; Thomas Roth; Chris Drake
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.